Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients

Rafael Luque; Zeid A. ALOthman; Alina M. Balu; Leonid Voskressensky

doi:10.3390/molecules26216738

Molecules (Nov 2021)

Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients

Rafael Luque,
Zeid A. ALOthman,
Alina M. Balu,
Leonid Voskressensky

Affiliations

Rafael Luque: Departamento de Química Orgánica, Campus de Rabanales, Universidad de Córdoba, Edificio Marie Curie (C-3), Ctra Nnal IV-A, Km 396, 14014 Cordoba, Spain
Zeid A. ALOthman: Chemistry Department, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
Alina M. Balu: Departamento de Química Orgánica, Campus de Rabanales, Universidad de Córdoba, Edificio Marie Curie (C-3), Ctra Nnal IV-A, Km 396, 14014 Cordoba, Spain
Leonid Voskressensky: Department of Chemistry, Peoples Friendship University of Russia (RUDN University), 6 Miklukho Maklaya St., 117198 Moscow, Russia

DOI: https://doi.org/10.3390/molecules26216738
Journal volume & issue: Vol. 26, no. 21
p. 6738

Abstract

Read online

A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide.

Published in Molecules

ISSN: 1420-3049 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Science: Chemistry: Organic chemistry
Website: http://www.mdpi.com/journal/molecules

About the journal

Abstract

Keywords